ROSEN, A TOP RANKED FIRM, Encourages AcelRx Pharmaceuticals, Inc. Investors to Secure Counsel Before Important August 9 Deadline in Securities Class Action - ACRXPRNewsWire • 07/04/21
SHAREHOLDER ALERT: Robbins LLP Reminds Investors That AcelRX Pharmaceuticals, Inc. (ACRX) is Being Sued for Misleading ShareholdersBusiness Wire • 07/01/21
Rosen, A Top Ranked Law Firm, Encourages AcelRx Pharmaceuticals, Inc. Investors to Secure Counsel Before Important August 9 Deadline in Securities Class Action - ACRXNewsfile Corp • 06/25/21
ACRX Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds AcelRx Pharmaceuticals, Inc. Investors of Class Action and Encourages Investors to Contact the FirmNewsfile Corp • 06/24/21
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages AcelRx Pharmaceuticals, Inc. Investors With Losses Over $100K to Secure Counsel Before Important August 9 Deadline in Securities Class Action – ACRXBusiness Wire • 06/23/21
ACRX INVESTOR ALERT: ROSEN, A LEADING AND LONGSTANDING LAW FIRM, Encourages AcelRx Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - ACRXPRNewsWire • 06/18/21
ACRX Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies AcelRx Pharmaceuticals, Inc. Investors of Class Action and Encourages Investors to Contact the FirmBusiness Wire • 06/17/21
AcelRx Announces Agreement with FDA Addressing the Warning Letter Received for DSUVIA® Promotional MaterialsPRNewsWire • 06/17/21
SHAREHOLDER ALERT: Robbins LLP Announces that AcelRX Pharmaceuticals, Inc. (ACRX) is Being Sued for Misleading ShareholdersBusiness Wire • 06/14/21
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of AcelRx Pharmaceuticals, Inc. (ACRX) InvestorsBusiness Wire • 06/14/21
ROSEN, RESPECTED INVESTOR COUNSEL, Encourages AcelRx Pharmaceuticals, Inc. Investors With Losses to Secure Counsel Before Important August 9 Deadline in Securities Class Action - ACRXPRNewsWire • 06/11/21
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against AcelRx Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmBusiness Wire • 06/11/21
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of AcelRx Pharmaceuticals, Inc. (ACRX) InvestorsBusiness Wire • 06/11/21
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of AcelRx Pharmaceuticals, Inc. (ACRX) on Behalf of InvestorsBusiness Wire • 06/10/21
ACRX Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies AcelRx Pharmaceuticals, Inc. Investors of Class Action and Encourages Investors to Contact the FirmPRNewsWire • 06/10/21
The Law Offices of Frank R. Cruz Announces Investigation of AcelRx Pharmaceuticals, Inc. (ACRX) on Behalf of InvestorsBusiness Wire • 06/09/21
SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against AcelRx Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmBusiness Wire • 06/09/21
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of AcelRx Pharmaceuticals, Inc. (ACRX) on Behalf of InvestorsBusiness Wire • 06/09/21
EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages AcelRx Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline – ACRXBusiness Wire • 06/09/21
ACELRX PHARMACEUTICALS ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against AcelRx Pharmaceuticals, Inc. and Encourages Investors to Contact the FirmBusiness Wire • 06/09/21
Pomerantz Law Firm Announces the Filing of a Class Action Against AcelRx Pharmaceuticals, Inc. and Certain Officers - ACRXPRNewsWire • 06/08/21
Rapid Discharge with Minimal PACU Opioids was Key Message During Presentation of DSUVIA® For Analgesia in Plastic Surgery Procedures at the California Society of Plastic Surgeons Annual MeetingPRNewsWire • 06/01/21
Presentation on the Use of DSUVIA® for Plastic Surgery Procedures Selected for "Best Papers" Session at the California Society of Plastic Surgeons Annual MeetingPRNewsWire • 05/26/21
